Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
SABS compared with IRD: revenue, margins and what each company keeps, and the suppliers and customers both name
SABS
SAB Biotherapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
IRD
Opus Genetics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
SABS
SAB Biotherapeutics, Inc.
vs
IRD
Opus Genetics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
SABS, solid
IRD, dashed
SABS
SAB Biotherapeutics, Inc.
Change
2.94
· pre 2.94
· delayed
Mkt cap
$264.9M
Revenue
$114,698
Q4 FY24
Revenue
—
IRD
Opus Genetics, Inc.
Change
4.02
· pre 4.06
· delayed
Pre-market
Nov 6 '26
delayed
Mkt cap
$355.2M
Revenue
$755,000
Q2 FY26
Revenue
$14M
FY25
vs
Compare
Pre-market
Nov 6 '26
delayed
SABS
SAB Biotherapeutics, Inc.
vs
IRD
Opus Genetics, Inc.
2.94
pre 2.94
delayed
Price
4.02
pre 4.06
delayed
$264.9M
Mkt cap
$355.2M
Q4 FY24
$114,698
Revenue
$755,000
Q2 FY26
—
Revenue
$14M
FY25
Change
Change
SABS
2.94
vs
IRD
4.02
Pre-market
Nov 6 '26
delayed